Leinco Technologies is a leader in the development and manufacturing of antibodies and recombinant proteins for early discovery research and diagnostics. In response to the ongoing worldwide pandemic, Leinco Technologies offers an extensive line of SARS-CoV-2 antibodies and antigens at the highest functional purity levels you have come to know and trust. Leinco’s COVID-19 Neutralization MICRO-ELISA and COVID-19 IgG Serology Assay has completed Section IV.D notification process under FDA’s “Policy for Coronavirus Disease – 2019 Test During the Public Health Emergency (Revised)“ and has not been reviewed by FDA.

SARS-CoV-2 (COVID-19)
Clone
Format
Reactive Species
Specificity
Host Species
Product Type
Reported Applications

Can't find what you're looking for?

Contact Leinco Technologies

10 per page
Sort by

Toggle Details

Showing 11 – 20 of 83 results Showing all 83 results Showing the single result No results found
- -
- -
Name
Applications ?
Prod No.
Clone
Pkg. Size / Quantity
Alt Names:
SARS-CoV Spike Antibody: E2, Spike glycoprotein, E2, S glycoprotein
Reactivity:
Virus
Immunogen:
Anti-SARS-CoV Spike antibody was raised against a peptide corresponding to 14 amino acids near the amino of SARS-CoV Spike glycoprotein. The immunogen is located within the first 50 amino acids of SARS-CoV Spike.
ELISA
S544
Max:
Min: 1
Step: 1
Alt Names:
SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Envelope protein, E protein
Reactivity:
Virus
Immunogen:
Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody was raised against a peptide corresponding to 10 amino acids near the amino terminus of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope protein. The immunogen is located within the first 50 amino acids of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope.
ELISA
S537
Max:
Min: 1
Step: 1
Alt Names:
COV2-1C7C7, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Protein N, SARS-CoV N Protein
Reactivity:
SARS-CoV-2
Virus
Immunogen:
Recombinant nucleoprotein of SARS-CoV (severe acute respiratory syndrome)
ELISA
,
IHC
,
WB
LT7000
1C7C7
Max:
Min: 1
Step: 1
Alt Names:
COV2-NP1-B9, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Protein N, SARS-CoV N Protein
Reactivity:
SARS-CoV-2
Virus
Immunogen:
SARS-CoV-2 Nucleocapsid (N) Protein
ELISA
LT7080
NP1-B9
Max:
Min: 1
Step: 1
Alt Names:
COV2-NP1-B9, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Protein N, SARS-CoV N Protein
Reactivity:
SARS-CoV-2
Virus
Immunogen:
SARS-CoV-2 Nucleocapsid (N) Protein
ELISA
LT7081
NP1-B9
Max:
Min: 1
Step: 1
Alt Names:
COV2-NP1-B9, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Protein N, SARS-CoV N Protein
Reactivity:
SARS-CoV-2
Virus
Immunogen:
SARS-CoV-2 Nucleocapsid (N) Protein
ELISA
LT7082
NP1-B9
Max:
Min: 1
Step: 1
Alt Names:
COV2-NP1-C5, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Protein N, SARS-CoV N Protein
Reactivity:
SARS-CoV-2
Virus
Immunogen:
SARS-CoV-2 Nucleocapsid (N) Protein
ELISA
LT7030
NP1-C5
Max:
Min: 1
Step: 1
Alt Names:
COV2-NP1-C5, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Protein N, SARS-CoV N Protein
Reactivity:
SARS-CoV-2
Virus
Immunogen:
SARS-CoV-2 Nucleocapsid (N) Protein
ELISA
LT7031
NP1-C5
Max:
Min: 1
Step: 1
Alt Names:
COV2-NP1-C5, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Protein N, SARS-CoV N Protein
Reactivity:
SARS-CoV-2
Virus
Immunogen:
SARS-CoV-2 Nucleocapsid (N) Protein
ELISA
LT7032
NP1-C5
Max:
Min: 1
Step: 1
Alt Names:
COV2-NP1-D4, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Protein N, SARS-CoV N Protein
Reactivity:
SARS-CoV-2
Virus
Immunogen:
SARS-CoV-2 Nucleocapsid (N) Protein
ELISA
LT7060
NP1-D4
Max:
Min: 1
Step: 1
1239